The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Very sorry to read your sad news Mac. Too many will be in the same situation as your friend's family if things are not speeded up when it comes to trials of drugs that may help. We have to wonder why it takes so long for some and is fast tracked for others. Warp speed? Hmm... Condolences to you and your friend's family. Wish we could change the circumstances.
I tried! Seems some people just can resist replying. We should be discussing the company not other posters and their possible trades in any other companies. There is a decent interview to discuss. That should be the focus.
Happy with the update. Looks like everything is still on track. Not sure I like the dates being given as they usually never materialize, but we shall see if "beginning of October" for Royston news, Coho online by 1st December (possibly a little earlier), and "shooting for April 1st" 2022 comes to be reality. Then we have news to come from the four legacy drills to come during that period (some of it at least).
Also nice to hear the the 22 Km seismic data looks "brilliant", and that no capital raises are planned. Let the wall of cash start flowing!
Doesn't look like I can edit the subject line or content of posts on LSE. The title should be "Nice move on Friday" of course.
There was a nice move here on Friday towards close of play. If KR1 ever moves to a more mainstream market the fun could really begin. Wonder if that will ever happen. Sure hope so!
Please would everyone just filter "Linton" or refrain from the temptation to respond? It would make the board so much better to be part of and reduce the noise. Nearly didn't bother reading the last two posts owing to the thread title, but they actually were quite useful!
Wishing all genuine long term holders who have faith in TXP the best. Let's hope that Royston is another positive drill result when the news comes.
Looks like the AGM is approaching. With luck some news may be approaching too!
Https://www.ii.co.uk/analysis-commentary/week-ahead-hays-crh-john-wood-group-ii521163
It is claimed that the companies with quiet BBs are those to keep an eye on. MSLH certainly fits into that category. No post in nearly a year! Results should be out soon. Perhaps even this week. Should be interesting to see how their UK focus has benefited them given the current logistical issues facing many companies around the world.
MSLH aren't exactly a "racy" holding as the price of 750p vs. 619 a year ago shows, but they pay a dividend and are one of my core holdings. Expect that to continue for years to come.
Thank you from me too Wally!
I said I wouldn't post here again until back at breakeven or in profit but since that will no doubt take quite a bit of time to become reality I thought I would just take the opportunity to thank you and note this part:
"What’s the forecast timeframe to get SP back to 40p?
Let’s see how we go, distressed shareholder now gone, company profitable, SP will rise nicely"
Let's hope CF's guidance actually results in the share price going in the right direction now! After all, if the distressed seller has gone, all should be seen through rose tinted specs now, right? GLA
Thank you for your view on the situation SeaBoy! Certainly opens the eyes when viewed from the "front line". I wish you and your colleagues all the best in this fight against COVID and also thank you for your hard (emotional as well as physical) work.
I note this part from your 1st post: "I'll clarify now that SNG001 isn't being used at my hospital."
Given your "belief" and experience in knowing about SNG's drug it does make one wonder "why?". Surely it would be worth banging the drum and making sure SNG001 was part of the trials at your hospital? I am sure it is not that easy to arrange and there are many things us laypeople are unaware of when it comes to organizing such trials.
I would also note, in response to this part - "Some populations out in the far east are even having trouble with the fact that this virus exists and that its effects are real which could explain why the uptake of vaccinations there is so poor. With the majority of these populations not having grasped the importance of vaccination, I doubt they'll be able to grasp the importance of any other prophylactic treatments such as Merck's pills in time for this wave or the next." - that in Thailand where I am based the population definitely knows the virus exists! So this part of your message is inaccurate. The take-up in vaccines is slower because of governments & no doubt some corruption. The people though are well aware of vaccines & their importance & are on the whole crying out for them. There are no incentives like "we will pay you money to have one" here, in fact there are queues whenever registration sites open & they are booked out within minutes!
Thank you for that clarification Thebhoys! Just wanted to make sure I hadn't missed something!
Your overview of past present, as well as a potential look into the future, looks great. I certainly believe, or I wouldn't be here, that the future is bright. However, it helps to have the sensible views of those more experienced with the BOD and area to fill in the blanks and further validate the opportunity. Cheers!
TheBhoys - I am a new investor here and noted your comment "TBH all I’m bothered is that I am invested and will be until the 07/07/ 23 and not a day longer."
Looks like I may have missed something obvious but please would you enlighten me on the significance of the date in 2023? Seems my limited due diligence wasn't diligent enough! Many thanks!
I know the question was addressed to DB, but I have noticed, as most long term shareholders have no doubt, that TXP have stepped up the social media posts on Twitter in particular: https://twitter.com/TouchstoneExp
This is where a lot of the news is being shared while we wait for any price sensitive or "needed" official releases via RNS announcements. With luck this "satisfies" most investor's desire for news while we wait.
**Let's get Coho online before we get carried away with dividends and (better still) share buybacks.**
I would personally not prefer share buybacks over dividends. From what I know, not that much perhaps, share buybacks usually only reward the BOD. They seldom benefit the smaller shareholders. Please correct me if mistaken, but there has been a lot of discussion about this point on the BB's of various companies over the years and that is the predominant conclusion that I have seen reached.
Of course, when we are in a position to discuss this down the line it will be even better as the share price will no doubt be somewhat higher than it is now! TXP is my largest holding by number and value. Hence, any dividend will be warmly received!
Well I am still here but have broken my word when I said I intended to refrain from posting until I was in profit! That was on 6th June when I made the comment and since then ORPH has gone in the wrong direction! I did buy some more to take myself to a nice round number as I said I may and in fact today I added a small number to that round number as well since I thought the last RNS was decent (lack of figures though!) and should have provided some support. Since CF hasn't announced he has bought any shares yet I am also interpreting this to mean that more news is on its way. Anyway, I am hoping that I am not be a complete idiot buying more at these levels and will be glad I did later. So far though every one of my 8 previous buys is under water so please don't look to me for investment advice!
Answers by query I suppose: https://www.hutch-med.com/wp-content/uploads/2021/07/a210706.pdf
1 Press Release HUTCHMED Initiates Phase ITrialsof novelERK inhibitor HMPL-295in Patientswith Advanced Solid Tumorsin ChinaHong Kong, Shanghaiand Florham Park, NJ —Tuesday, July6,2021:HUTCHMED (China)Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX: 13) has initiated a Phase I studyof HMPL-295, its investigative and highly selective oral inhibitor of ERK, whichis a downstream component of the RAS-MAPK1pathway signaling cascade. HMPL-295has the potential to address intrinsic or acquired resistance from upstream mechanisms such as RAS, RAFand MEK.This is our first of multiple candidates in discovery addressing the RAS-MAPK pathway.The first patient was dosed on July2, 2021.
Looks like news may be released in HK 1st from now on unless really important and possibly UK timing as an average of all time zones?
So now that we have listings on the AIM, Nasdaq and HKEX I assume the news releases will come, per the last one, around midday from now on since the HKEX is regarded as home territory. Does that seem to be correct or do we still expect a few 7.00 am UK time news releases?
Nice to see such a positive debut on the HKEX amones! Currently HK$ 63 Https://www.hkex.com.hk/Market-Data/Securities-Prices/Equities/Equities-Quote?sym=13&sc_lang=en
My bet would have been wrong if I placed it. Didn't expect such strength, but then we have only just begun. Let's see if we can maintain the trend. UK and US trading today will be very interesting!
No! Predicting is a fools game. Would love it to go up and be well received, but we will not know until the time comes. All we can say is that HCM looks to have "turned the corner" given the latest news and pending listing/trading. It has reached an overbought position on the RSI so who knows what will happen now! Place your bets!
Scott22 - I think that evidence of income from Coho will be an important factor, so while news about a hook-up may not do wonders it should help as it removes some uncertainty from the equation. It will be income that really makes the difference though. A bit more of a wait on that one but hopefully not on a resolution with Shell or something that removes the existing uncertainty that shorters are using to their advantage.